A historic shift in our drug policy has taken place, as the regulators allow the availability of psilocybin hallucinogens for therapeutic applications. Until now, these substances were heavily restricted, but a mounting body of studies suggests they could offer benefits for emotional conditions like anxiety. This development represents a key step t